Efficacy of narrowband ultraviolet B phototherapy and levels of serum vitamin D3 in psoriasis: A prospective study
- PMID: 27057487
- PMCID: PMC4804600
- DOI: 10.4103/2229-5178.178081
Efficacy of narrowband ultraviolet B phototherapy and levels of serum vitamin D3 in psoriasis: A prospective study
Abstract
Introduction: Narrowband ultraviolet B phototherapy (NBUVB) is safe and effective treatment for psoriasis. Vitamin D plays an important role in pathogenesis of psoriasis. It is known that psoriasis patients have low serum 25(OH)D levels, which increase after NBUVB. We assessed serum 25(OH)D levels, its correlation with Psoriasis Area and Severity Index (PASI), and the effect of NBUVB on 25(OH)D levels among Indian psoriasis patients.
Materials and methods: A prospective study comprising 30 adults with psoriasis with no major comorbidities (PASI > 10 and off-therapy >4 weeks) was conducted. PASI was estimated at baseline among patients and repeated after receiving 12 weeks of NBUVB therapy. Thirty age and gender-matched healthy controls were recruited to compare 25(OH)D levels at baseline and at 12 weeks. Patient demographic parameters, treatment dose, duration, side effects, and its impact on 25(OH)D levels and PASI were serially evaluated.
Results: A total of 30 patients presenting with psoriasis and 30 healthy controls were enrolled in the study. Mean baseline PASI (M: F =19:11) among patients with mean age 36.8 (±7.7) years was 20.5 (±6.3) and all patients were either 25(OH)D deficient (n = 14) or insufficient (n = 16). Their baseline 25(OH)D levels were significantly lower than controls (25.93 nmol/L vs 47.54 nmol/L; P < 0.001). After NBUVB therapy (average cumulative dose 20.76 ± 7.1 J/cm(2); average treatment sessions 32.57 ± 1.9), there was a significant improvement in PASI as well as 25(OH)D (P < 0.05). There was no correlation between the mean improvement in PASI and 25(OH)D after 12 weeks of therapy. Twelve (40%) patients had therapy-related side effects [pruritus (n = 8), erythema (n = 4)], none had major side effects.
Conclusion: Improvement in PASI and serum 25(OH)D levels after NBUVB in psoriasis is significant but poorly correlated with each other. Vitamin D may not be the lone mediator of the therapeutic effects of NBUVB on psoriasis.
Keywords: Narrowband ultraviolet B phototherapy; psoriasis; vitamin D.
Figures

Similar articles
-
Vitamin D status in psoriasis patients during different treatments with phototherapy.J Photochem Photobiol B. 2010 Nov 3;101(2):117-23. doi: 10.1016/j.jphotobiol.2010.05.008. Epub 2010 May 26. J Photochem Photobiol B. 2010. PMID: 20579901 Clinical Trial.
-
Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis--a randomized single-blinded placebo-controlled study.J Eur Acad Dermatol Venereol. 2010 May;24(5):595-600. doi: 10.1111/j.1468-3083.2009.03486.x. Epub 2009 Dec 15. J Eur Acad Dermatol Venereol. 2010. PMID: 20015056 Clinical Trial.
-
Vitamin D production in psoriasis patients increases less with narrowband than with broadband ultraviolet B phototherapy.Photodermatol Photoimmunol Photomed. 2009 Jun;25(3):119-23. doi: 10.1111/j.1600-0781.2009.00418.x. Photodermatol Photoimmunol Photomed. 2009. PMID: 19438988
-
Use of narrowband ultraviolet B (NBUVB) in paediatric psoriasis: A systematic literature review and meta-analysis.Australas J Dermatol. 2021 May;62(2):124-129. doi: 10.1111/ajd.13471. Epub 2020 Oct 18. Australas J Dermatol. 2021. PMID: 33070303
-
Association between circulating 25-hydroxyvitamin D levels and psoriasis, and correlation with disease severity: a meta-analysis.Clin Exp Dermatol. 2018 Jul;43(5):529-535. doi: 10.1111/ced.13381. Epub 2018 Jan 16. Clin Exp Dermatol. 2018. PMID: 29341195 Review.
Cited by
-
Proposed Neuroimmune Roles of Dimethyl Fumarate, Bupropion, S-Adenosylmethionine, and Vitamin D3 in Affording a Chronically Ill Patient Sustained Relief from Inflammation and Major Depression.Brain Sci. 2020 Aug 31;10(9):600. doi: 10.3390/brainsci10090600. Brain Sci. 2020. PMID: 32878267 Free PMC article. Review.
-
Vitamin D Receptor Expression in Chronic Plaque Psoriasis Before and After Narrowband Ultraviolet B Phototherapy.J Cutan Aesthet Surg. 2023 Apr-Jun;16(2):128-133. doi: 10.4103/JCAS.JCAS_122_22. J Cutan Aesthet Surg. 2023. PMID: 37554687 Free PMC article.
-
Psoriasis: Are Your Patients D-pleted? A Brief Literature Review on Vitamin D Deficiency and Its Role in Psoriasis.J Clin Aesthet Dermatol. 2022 Mar;15(3 Suppl 1):S30-S33. J Clin Aesthet Dermatol. 2022. PMID: 35382439 Free PMC article. Review.
-
Extra-Skeletal Effects of Vitamin D.Nutrients. 2019 Jun 27;11(7):1460. doi: 10.3390/nu11071460. Nutrients. 2019. PMID: 31252594 Free PMC article. Review.
References
-
- Gudjonsson JE, Elder JT. Psoriasis. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's Dermatology In General Medicine. 7th ed. Vol. 1. USA: McGraw-Hill; 2008. p. 169.
-
- Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol. 2002;46:1–26. - PubMed
-
- Kira M, Kobayashi T, Yoshikawa K. Vitamin D and the skin. J Dermatol. 2003;30:429–37. - PubMed
-
- Lehmann B. The vitamin D3 pathway in human skin and its role for regulation of biological processes. Photochem Photobiol. 2005;81:1246–51. - PubMed
-
- Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 2001;167:4974–80. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources